Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light.
about
Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical useCurrent methods for the reduction of blood-borne pathogens: a comprehensive literature reviewPathogen inactivation technologies for cellular blood components: an updateA pilot study to assess the hemostatic function of pathogen-reduced platelets in patients with thrombocytopenia.Observational study of corrected count increments after transfusion of platelets treated with riboflavin pathogen reduction technology in additive solutions.Pathogen reduction/inactivation of products for the treatment of bleeding disorders: what are the processes and what should we say to patients?Improving the safety of whole blood-derived transfusion products with a riboflavin-based pathogen reduction technology.Component pathogen inactivation: a critical review.Chemical and biological mechanisms of pathogen reduction technologiesIn vitro and in vivo characterization of ultraviolet light C-irradiated human platelets in a 2 event mouse model of transfusionPrimary hemostatic capacity of whole blood: a comprehensive analysis of pathogen reduction and refrigeration effects over time.The effect of riboflavin and ultraviolet light on the infectivity of arboviruses.One size will never fit all: the future of research in pediatric transfusion medicine.The Effects of Ultraviolet Light and Riboflavin on Inactivation of Viruses and the Quality of Platelet Concentrates at Laboratory Scale.Introducing Pathogen Reduction Technology in Poland: A Cost-Utility AnalysisTreatment of Whole Blood With Riboflavin and UV Light: Impact on Malaria Parasite Viability and Whole Blood StoragePhotochemical eradication of methicillin-resistant Staphylococcus aureus by blue light activation of riboflavin.Usutu virus.New treatments for bacterial keratitis.Update on the use of pathogen-reduced human plasma and platelet concentrates.Corneal collagen cross-linking for infectious keratitis: an update of clinical studies.Laboratory Evaluation of the Effectiveness of Pathogen Reduction Procedures for BacteriaRiboflavin and ultraviolet light: impact on dengue virus infectivity.Riboflavin-ultraviolet light pathogen reduction treatment does not impact the immunogenicity of murine red blood cells.The effectiveness of riboflavin photochemical-mediated virus inactivation and changes in protein retention in fresh-frozen plasma treated using a flow-based treatment device.Inactivation of Plasmodium falciparum in whole blood by riboflavin plus irradiation.Pathogen reduction of whole blood: utility and feasibility.Inactivation of model viruses and bacteria in human fresh frozen plasma using riboflavin and long wave ultraviolet rays.Treatment of buffy coat platelets in platelet additive solution with the mirasol(®) pathogen reduction technology system.Efficiency of riboflavin and ultraviolet light treatment against high levels of biofilm-derived Staphylococcus epidermidis in buffy coat platelet concentrates.Red blood cells derived from whole blood treated with riboflavin and ultraviolet light maintain adequate survival in vivo after 21 days of storage.Risks associated with red blood cell transfusions: potential benefits from application of pathogen inactivation.Treatment of Platelet Concentrates with the Mirasol Pathogen Inactivation System Modulates Platelet Oxidative Stress and NF-κB Activation.Effect of increased agitation speed on pathogen inactivation efficacy and in vitro quality in UVC-treated platelet concentrates.The efficiency of cross-linking methods in eradication of bacteria is influenced by the riboflavin concentration and the irradiation time of ultraviolet light.Investigating the prevalence of transfusion transmission of Plasmodium within a hyperendemic blood donation system.Pathogen inactivation efficacy of Mirasol PRT System and Intercept Blood System for non-leucoreduced platelet-rich plasma-derived platelets suspended in plasma.Development of a riboflavin and ultraviolet light-based device to treat whole blood.Pathogen Reduction in Blood Products: What's Behind These Techniques?Comparison of UVA- and UVA/riboflavin-induced growth inhibition of Acanthamoeba castellanii.
P2860
Q26741073-B9589E1A-3FB9-4E0B-AA8E-8103CD4276A0Q26996247-D5CB0DDE-E541-41A2-B4FD-550EC98D56EAQ28655769-3D395416-B72E-4E2B-911D-90A8E265A95AQ33405052-E2578253-49BE-4BC2-B11A-71CE94FFF978Q33420599-77038C13-1EC7-4DB9-ADB2-6E91ACCFEAFAQ33841435-3A47A241-A39F-49C8-B42F-42774BFC20B2Q33852543-F372B154-94CA-459D-9F43-448D0A091862Q34310415-2E6D4100-7890-42CA-9386-ADCFFE5EDEC7Q34777948-D73A69A6-B2E5-4A74-8E30-87BA17C7365BQ35041519-577FA329-2071-4228-A440-2A5FFFA5AAE8Q35064119-9EFC72C6-F170-4461-8255-4E226230FB19Q35394095-72FD2985-3C3E-4178-A91D-F68081E56AFBQ35535157-02EDBE04-0D28-443E-831D-A6A4FCE3637BQ35682144-E5E56A66-8358-4E23-B8D7-4FC5163F7632Q35789569-078D37C9-0F34-4EAE-9755-A699539E103CQ35841288-80EC1E43-0BC3-484A-A08D-A7E437D515A1Q36282177-0A830170-47B7-41D6-B475-61ADE41D40D4Q37630301-C2E75489-3E36-4DE8-A5C5-C8535722368FQ38044726-A4553ED3-2BB0-4DE5-9328-50DCB39A329EQ38109665-C07E69E5-2FB6-440D-8E73-12D0A62D17A2Q38491908-A2CCD2E8-FC4F-4996-89B9-70363101B032Q38667338-858F4EED-D706-4829-B295-2CADF2090031Q38808618-4764C0F4-432E-4102-9C2F-D9117B835EF4Q38934537-3193E45F-FCE6-44EE-ACEF-0CDF17D8EAF6Q38970859-4BD302A4-8529-4DF4-A101-94A7401D3747Q38984286-E41C5BAD-3D64-460F-8084-B25BA113FC16Q40056466-8191B08A-7E48-4466-865E-560A9E193FBCQ40095226-3ED5BD88-370C-4CE1-A40F-FBD58C8DD094Q40100501-DEF0E88B-6D68-4F06-BA5D-FED599C1C92BQ40264266-B0ABB061-9775-4A2E-A06E-ADBBBAB71383Q40267288-164A7E84-17FD-4DD2-A170-4BCC0D53BF4CQ40611312-66DF0F2C-FC7B-4A3B-98F0-80606042B9A2Q40713949-ABA78715-31EC-4951-B20B-8FCAD8980919Q40759847-22698AED-E205-43AE-94F8-EF64908FB346Q41606941-604A716C-E3AE-446E-AE22-7EF3472B1801Q41927939-CC163AD3-4502-453C-BF8E-37C91387F69DQ42220047-820F1CB8-4BF8-49BD-B873-E1F071F94DADQ42278634-A9255D1E-1639-47D8-94A8-7DA45F546920Q42792667-5B2F9994-A511-45B4-BC15-7DDFF09B9860Q43782104-21DD1FFC-DE5F-4D50-9994-C7D05F68F045
P2860
Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pathogen Reduction Technology ...... Using Riboflavin and UV Light.
@en
Pathogen Reduction Technology ...... Using Riboflavin and UV Light.
@nl
type
label
Pathogen Reduction Technology ...... Using Riboflavin and UV Light.
@en
Pathogen Reduction Technology ...... Using Riboflavin and UV Light.
@nl
prefLabel
Pathogen Reduction Technology ...... Using Riboflavin and UV Light.
@en
Pathogen Reduction Technology ...... Using Riboflavin and UV Light.
@nl
P2860
P356
P1476
Pathogen Reduction Technology ...... Using Riboflavin and UV Light
@en
P2093
Susanne Marschner
P2860
P356
10.1159/000324160
P577
2011-01-31T00:00:00Z